Fig. 1From: Lessons learned: establishing a CLIA-equivalent laboratory for targeted mass spectrometry assays – navigating the transition from research to clinical practicePreparation, timeline and milestone to establish an immuno-multiple reaction monitoring (iMRM) mass spectrometry-based thyroglobulin assay meeting the Clinical Laboratory Improvement Amendments (CLIA) guidelineBack to article page